Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.
Also called NCT03699215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 184 participants
- Sponsor
- Hospital Universitario de Canarias
- Registry
-
NCT03699215
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT03699215. Randomized; triple masking; primary purpose treatment. Start 2018-11-17 (actual); primary completion 2020-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan
- Acronym
- LEVOCEST
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- Levosimendan
- Intervention (Drug)
- Placebos
- Lead sponsor
- Hospital Universitario de Canarias
Record details
- Record id
cardio:ct-nct03699215- Content hash
18ccf9c91b89cc9ec5512d1888327fe7ff948ff09f773c7df65d56f504c7a763